Clinical Trials Directory

Trials / Completed

CompletedNCT06353165

Anti-bacterial Clinical Study on Teeth, Tongue, Cheek, Gum, and Saliva

A Clinical Study to Investigate Stannous Fluoride Toothpaste on Antibacterial Effects in the Different Regions of the Mouth as Compared to Colgate Cavity Protection Toothpaste

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Colgate Palmolive · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

This 4-week clinical study was designed to examine the antibacterial efficacy of brushing with a 0.454% stannous fluoride toothpaste with potassium nitrate and pyrophosphate compared to a toothpaste containing 0.76% MFP (marketed as Colgate Cavity Protection Toothpaste) in different regions of the mouth (dental plaque, tongue, cheek, gum surface and in saliva) 12 hours post-brushing (overnight) after 2 and 4 weeks of product use.

Conditions

Interventions

TypeNameDescription
DRUGStannous fluoride toothpasteproduct containing 0.45% stannous fluoride
DRUGColgate Dental Creamproduct containing 0.76% sodium monofluorophosphate

Timeline

Start date
2023-03-08
Primary completion
2023-04-12
Completion
2023-04-12
First posted
2024-04-08
Last updated
2024-04-15

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT06353165. Inclusion in this directory is not an endorsement.